HLA class II is a factor in cardiovascular morbidity and mortality rates in patients with type 1 diabetes

被引：0
|
作者：
J. Söderlund
C. Forsblom
J. Ilonen
L. M. Thorn
J. Wadén
M. Parkkonen
P.-H. Groop
机构：
[1] University of Helsinki,Folkhälsan Research Center, Biomedicum Helsinki
[2] Helsinki University Central Hospital,Department of Medicine, Division of Nephrology Helsinki
[3] University of Turku,Immunogenetics Laboratory
[4] University of Eastern Finland,Department of Clinical Microbiology
[5] Baker IDI Heart and Diabetes Institute,undefined
来源：
Diabetologia | 2012年 / 55卷
关键词：
Cardiovascular disease; Human leucocyte antigen; Mortality; Type 1 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2963 / 2969
页数：6
相关论文
共 50 条
  • [31] Rosiglitazone [Avandia] does not increase the risk of cardiovascular mortality and morbidity in patients with type 2 diabetes mellitus
    Reactions Weekly, 2008, 1206 (1) : 5 - 5
  • [32] Microalbuminuria and clinical proteinuria as the main predictive factors of cardiovascular morbidity and mortality in patients with type 2 diabetes
    Orna, JAG
    Juliani, BB
    Arnal, LML
    Alonso, FJC
    REVISTA CLINICA ESPANOLA, 2003, 203 (11): : 526 - 531
  • [33] Reduced cardiovascular morbidity and mortality associated with metformin use in type 2 diabetes
    Johnson, JA
    Majumdar, SR
    Simpson, SH
    Toth, EL
    DIABETES, 2002, 51 : A231 - A231
  • [34] Diabetic retinopathy as a predictor of cardiovascular morbidity and mortality in subjects with type 2 diabetes
    Barrot, Joan
    Real, Jordi
    Vlacho, Bogdan
    Romero-Aroca, Pedro
    Simo, Rafael
    Mauricio, Didac
    Mata-Cases, Manel
    Castelblanco, Esmeralda
    Mundet-Tuduri, Xavier
    Franch-Nadal, Josep
    FRONTIERS IN MEDICINE, 2022, 9
  • [35] Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes
    Ferreira-Divino, Luis F.
    Suvitaival, Tommi
    Curovic, Viktor Rotbain
    Tofte, Nete
    Trost, Kajetan
    Mattila, Ismo M.
    Theilade, Simone
    Winther, Signe A.
    Hansen, Tine W.
    Frimodt-Moller, Marie
    Legido-Quigley, Cristina
    Rossing, Peter
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [36] Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes
    Luis F. Ferreira-Divino
    Tommi Suvitaival
    Viktor Rotbain Curovic
    Nete Tofte
    Kajetan Trošt
    Ismo M. Mattila
    Simone Theilade
    Signe A. Winther
    Tine W. Hansen
    Marie Frimodt-Møller
    Cristina Legido-Quigley
    Peter Rossing
    Cardiovascular Diabetology, 21
  • [37] Sex differences in mortality and rates of cardiovascular disease in patients with diabetes
    Malmborg, M.
    Schmiegelow, M.
    Gerds, T.
    Schou, M.
    Hlatky, M.
    Kistorp, C.
    Gislason, G.
    EUROPEAN HEART JOURNAL, 2018, 39 : 462 - 462
  • [38] Application of type II diabetes incidence and mortality rates for insurance
    Yue, Jack C.
    Wang, Hsin-Chung
    Chang, Ting-Chung
    PLOS ONE, 2024, 19 (09):
  • [39] HLA CLASS-II ANTIGENS AND INTERLEUKIN-1 IN PATIENTS AFFECTED BY TYPE-II DIABETES-MELLITUS AND HYPERLIPEMIA
    ROMANOCARRATELLI, C
    GALDIERO, M
    BENTIVOGLIO, C
    NUZZO, I
    COZZOLINO, D
    TORELLA, R
    JOURNAL OF MEDICINE, 1993, 24 (01) : 28 - 34
  • [40] HLA class II SNP interactions and the association with type 1 diabetes mellitus in Bengali speaking patients of Eastern India
    Oindrila Raha
    Biswanath Sarkar
    Bhaskar VKS Lakkakula
    Veerraju Pasumarthy
    Sudhakar Godi
    Subhankar Chowdhury
    Pradip Raychaudhuri
    Raghavendra Rao Vadlamudi
    Journal of Biomedical Science, 20
12345